These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7050431)

  • 21. Propranolol and giving up smoking.
    Farebrother MJ; Pearce SJ; Turner P; Appleton DR
    Br J Dis Chest; 1980 Jan; 74(1):95-6. PubMed ID: 6986897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment adherence and risk of death after a myocardial infarction.
    Horwitz RI; Viscoli CM; Berkman L; Donaldson RM; Horwitz SM; Murray CJ; Ransohoff DF; Sindelar J
    Lancet; 1990 Sep; 336(8714):542-5. PubMed ID: 1975045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of propranolol on mortality and morbidity after acute myocardial infarction.
    Abela GS; Mehta J; Conti CR
    J Fla Med Assoc; 1982 Jun; 69(6):453-7. PubMed ID: 7097220
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction].
    Halawa B; Mazurek W
    Wiad Lek; 1986 Jan; 39(1):25-30. PubMed ID: 2872756
    [No Abstract]   [Full Text] [Related]  

  • 25. [Propranolol (Inderal) in acute myocardial infarct].
    Nielsen BL; Jorgensen FS; Clausen J; Felsby M; Roin J; Strange B
    Ugeskr Laeger; 1967 May; 129(21):689-96. PubMed ID: 4877646
    [No Abstract]   [Full Text] [Related]  

  • 26. The relationship of treatment adherence to the risk of death after myocardial infarction in women.
    Gallagher EJ; Viscoli CM; Horwitz RI
    JAMA; 1993 Aug; 270(6):742-4. PubMed ID: 8336377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack Trial.
    Byington RP; Curb JD; Mattson ME
    JAMA; 1985 Mar 22-29; 253(12):1733-6. PubMed ID: 3974051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-adrenergic blockade for survivors of acute myocardial infarction.
    Frishman WH; Furberg CD; Friedewald WT
    N Engl J Med; 1984 Mar; 310(13):830-7. PubMed ID: 6142420
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of acute myocardial infarction with propranolol.
    Snow PJ
    Am J Cardiol; 1966 Sep; 18(3):458-62. PubMed ID: 5922890
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravenous propranolol in acute myocardial infarction.
    Norris RM; Brown MA
    Lancet; 1985 Jan; 1(8419):56. PubMed ID: 2856987
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of obsidan and labetalol on the course of myocardial infarction].
    Sirenko IuN; Mironova OV; Ivanova DK; Shkliar LV
    Vrach Delo; 1988 Jun; (6):20-3. PubMed ID: 3047990
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-dysrhythmic treatment in acute myocardial infarction.
    Lancet; 1979 Jan; 1(8109):193-4. PubMed ID: 84210
    [No Abstract]   [Full Text] [Related]  

  • 33. The Norwegian propranolol trial in selected patients.
    Hansteen V
    Br J Clin Pharmacol; 1982; 14 Suppl 1(Suppl 1):9S-12S. PubMed ID: 7052112
    [No Abstract]   [Full Text] [Related]  

  • 34. A controlled trial of propranolol in acute myocardial infarction.
    Balcon R; Jewitt DE; Davies JP; Oram S
    Am Heart J; 1967 Oct; 74(4):582-4. PubMed ID: 4860252
    [No Abstract]   [Full Text] [Related]  

  • 35. Long term propranolol treatment and changes in body weight after myocardial infarction.
    Rössner S; Taylor CL; Byington RP; Furberg CD
    BMJ; 1990 Apr; 300(6729):902-3. PubMed ID: 2186832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propranolol in the therapy of ischaemic heart disease with angina pectoris.
    Banerjea JC; Mukherjee SK; Mukherjee TP
    Indian Heart J; 1969 Jul; 21(3):259-72. PubMed ID: 4904075
    [No Abstract]   [Full Text] [Related]  

  • 37. [Inderal in the acute and post-myocardial infarct periods].
    Popov VG; Martynov IV; Alushkov MV; Voronin VA
    Ter Arkh; 1986; 58(6):53-8. PubMed ID: 3764715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prophylactic use of propranolol in acute coronary occlusion. A double-blind study].
    Jacobsen K; Carstens PH
    Ugeskr Laeger; 1968 May; 130(22):936-9. PubMed ID: 4880860
    [No Abstract]   [Full Text] [Related]  

  • 39. Adherence to treatment and health outcomes.
    Horwitz RI; Horwitz SM
    Arch Intern Med; 1993 Aug; 153(16):1863-8. PubMed ID: 8250647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of propranolol on blood lipids and lipoproteins in myocardial infarction.
    Shulman RS; Herbert PN; Capone RJ; McClure D; Hawkins CM; Henderson LO; Saritelli A; Campbell J
    Circulation; 1983 Jun; 67(6 Pt 2):I19-21. PubMed ID: 6851036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.